The CCB seminar Friday March 31st will be held by Pierre Leopold, PhD, Group Leader at the Institut de Biologie Valrose, and Research Director for the National Institute of Health and Medical Research (INSERM), University of Nice.
Title of his talk: Growth coordination during development
Time and place: Friday March 31st at 12:00 PM - 01:00 PM in Seminar room 1 in the Research Building, Institute for Cancer Research, Montebello.
“Centre for Cancer Cell Reprogramming”, affiliated with the Institute of Clinical Medicine at University of Oslo, has been funded by the Research Council of Norway as a new Centre of Excellence.
Jørgen Wesche appointed group leader for the Mesenchymal Cancer Biology Group at the Department of Tumor Biology
Jørgen Wesche earned his PhD in Sjur Olsnes's group in 2001, studying intracellular transport and membrane translocation. During his postdoctoral training, spending some time at Institute Curie in Paris, he has changed his focus towards problems with more translational relevance, specializing in live cell imaging, fibroblast growth factor receptor (FGFR) signaling and importance of FGFR in cell migration/invasion. Aberrations in FGFR signaling are found in several types of sarcoma and that´s the main reason way Jørgen started to get interested in sarcoma biology and treatment. He has several exciting ideas on how to further develop his research into more translational/clinical relevance.
Professor Per Ottar Seglen, formerly head of the Proteomics & Mammalian Cell Biology Section at the Institute for Cancer Research, OUH, currently a guest researcher at NCMM, has been awarded the prestigious King Olav V’s prize for Cancer Research 2017.
The award, formally announced by the Norwegian Cancer Society today, is recognized as one of the Norwegian cancer research community’s most respected prizes. Professor Seglen has been awarded the prize in recognition of his ground-breaking research into autophagic-lysosomal protein degradation and its relationship to cancer.
The prize will be officially presented by King Harald V, on behalf of the Cancer Society, at a special ceremony on 6 June 2017. The prize is NOK 1 million.
The upcoming Institute Seminar will take place Wednesday 22th of February at 12:00 in the auditorium in the Research Building, Montebello.
Speaker is Tord Homeland, and the title of his talk is:
"Core Facility for preclinical imaging (MRI and IVIS). What services can we offer?"